3

OWNERSHIP DOCUMENT

Company: Protalix BioTherapeutics, Inc.
Filed: July 5, 2022
Period of Report: June 30, 2022
Accession Number: 0001104659-22-077371

View Document ↗ View on SEC.gov ↗